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ABSTRACT. In this research, direct batch and flow injection (FI) spectrophotometric methods for the analysis 
of piroxicam (PIX) in commercial dosage forms were investigated. The methods were based on the reaction of 
PIX with diazotized metoclopramide in alkaline medium to form orange color product at room temperature which 
absorbs maximally at λmax 472 nm. Chemical and physical variables of batch and FI methods were optimized to 
produce high sensitivity and reproducibility. Under the optimized experimental conditions, Beer’s law was obeyed 
over concentration ranges from 1 - 35 and 10 - 250 μg/mL PIX with limits of detection of 0.2 and 3.4 μg/mL and 
limits of quantification of 0.7 and 11.4 μg/mL PIX for batch and FI procedures, respectively. The relative standard 
deviation (%RSD) was less than 0.7 and 2.4 for batch and FI procedures respectively with a sample throughput of 
38 h-1 for FI procedure. The proposed methods can be used for the routine analysis for the assay of PIX in 
injections and capsules. 
  




Piroxicam (PIX) (C15H13N3O4S) is chemically known as 4-hydroxy-2-methyl-3-(N-pyridil-2)-
carboxyamido-2H-,2-benzothiazine-1,1-dioxide. It is a non-steroidal anti-inflammatory agent 
that is widely used in the treatment of inflammatory conditions such as rheumatic fever, 
rheumatoid arthritis, non-specific polyarthritis, and osteoarthritis [1]. Therapeutic dose of PIX is 
20 mg daily, but it can cause several gastrointestinal upset symptoms at high dose [2], therefore, 
the assay of PIX is recommended to gain the optimal therapeutic level and to ensure good 
quality assurance in pharmaceutical products. PIX has been determined by several reported 
methods included high performance liquid chromatography (HPLC) [3, 4], extraction by 
magnetic imprinted polymeric nanosorbent [5], ultrasonic assisted magnetic dispersive solid 
phase microextraction [6], capillary electrophoresis (CE) [7, 8], and voltammetry [9]. The 
literature reported several spectrophotometric methods [10-20] and a few flow injection 
methods [21-24] for the determination of PIX in dosage forms. Most of these methods involved 
redox reactions [10-13], or formation of ion association complexes with basic dyes [14, 15]. 
However, most of these methods are indirect [11, 18, 19] or suffer from disadvantages such as 
dependence on temperature, poor reproducibility, instability of the colored product, time 
consuming and unsuitable for routine analysis of the drug. As a result, the development of the 
direct, rapid and inexpensive method for the assay of PIX in pharmaceutical forms is essential. 
Flow-injection analysis (FIA) is considered as speed and inexpensive technique used in routine 
analysis. It is very useful for the automated reactions which do not reach equilibrium or those 
not sufficiently stable over time [25, 26]. The present work describes the development of direct 
batch and FIA methods for the determination of PIX using another drug (metoclopramide (MP)) 
as a green and safe reagent. The diazotization coupling reaction between PIX and diazotized 
metoclopramide (DMP) in the presence of sodium hydroxide as an alkaline medium produced 
orange product measured spectrophotometrically at 472 nm. The methods are applied for the 
assay of PIX in pure and dosage forms.  
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The absorbance measurements were performed using a Shimadzu UV-Visible 1240 digital 
single beam recording spectrophotometer. Flow injection equipment involved a flow cell (50 μL 
and 1 cm path length), a peristaltic pump (Ismatec, Labortechnik–Analytik, CH–8152, 
Switzerland) used for pumping the solutions. Also, an injection valve (Rheodyne, Altex 210, 
Supelco-USA) used for injection microliter volumes of samples. Solutions of reagents were 
pumped through a flexible vinyl tubing (0.5 mm i.d.), while the reaction coil (RC) was made 
from Teflon tubes (0.5 mm i.d.). A double-channel manifold (Figure 1) was adopted for 
applying the FI procedure. The first channel was used for transport DMP, while the other one 
used for transport NaOH solution. Through the injection valve, PIX solution was injected into 
the stream of the DMP and then mixed with the base in RC. The peristaltic pump (total flow rate 
of 1.47 mL/min was used for propelled the solution during the manifold. The absorbance of the 














Figure 1. FIA manifold (I.V, injection valve; PIX, piroxicam; P, peristaltic pump; R.C, reaction 




All reagents used were of analytical reagent grade. The standard materials of PIX and MP 
(99.9% pure) also the excipients were kindly donated by the Iraqi Pharmaceutical 
Manufacturing Company (SDI-Samarra/Iraq). HPLC grade ethanol was obtained from Sigma-
Aldrich (USA). Pharmaceutical forms of PIX (Piroxicam® capsules 20 mg/Micro Labs 
limited/Indian-SOTILEN 10 mg capsules/Cyprus-Feldene injection-Piroxicam 20 mg/1 mL-
Pfizer/USA) were purchased from the local market. Sodium hydroxide and sodium nitrite were 
supplied from Merck (Germany). HCl (36% w/w) was an analytical-reagent grade and 
purchased from Sigma-Aldrich (USA). 
 
Preparation of standard and reagents solutions 
 
Piroxicam standard solution (250 μg/mL). A 0.0250 g of PIX was dissolved in 25 mL ethanol in 
a 100 mL volumetric flask and then the solution was completed to the mark with distilled water. 
The working standard solution was prepared by simple diluting with distilled water. 
 
Diazotized metoclopramide hydrochloride (5 mM). This solution was prepared daily by 
weighing a 0.1772 g of MP and dissolved in a minimum volume of distilled water in a 100 mL 
volumetric flask then 3 mL of 1 M HCl was added while keeping the temperature of the solution 
at 0-5 oC for 5 min in ice–bath. A weight of 0.0345 g amount of NaNO2 was added with shaking 
for 5 min and then completed the volume to the mark with distilled water. 
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Sodium hydroxide solution (0.1 M). A 1 g of the NaOH was dissolved in 250 mL distilled water 
and then standardized. 
 
Hydrochloric acid solution (1 M). Prepared diluted acid solution was made by appropriate 
dilution of 85.84 mL of concentrated solution (11.65 M) with 1 L distilled water in a volumetric 
flask. 
 
Analysis of PIX in capsules and injections  
 
Weighed and mixed the contents of 10 capsules or mixed content of 5 vials (commercially 
available). An accurately weighed amount of the powder (equivalent to 25 mg of the pure drug 
contents), were taken and dissolved in 25 mL ethanol and completed the 100 mL calibrated flask 
to the mark with distilled water into. The flasks were shaken well for 15 min then filtered. The 




A series of volumes of standard PIX solution, covering the concentration range of 1-35 μg/mL, 
were transferred into a series of 10 mL standard volumetric flasks. To each flask, 1.0 mL of 
DMP (5 mM) and 1.5 mL of NaOH (0.1 M) solution were transferred then diluted with distilled 
water and mixed well. The reaction reaches to maximum intensity and stability after 5 min, then 
the absorbance was measured at 472 nm (at 25 oC) against reagent blank. The amount of the PIX 
was obtained from the regression equation of the calibration graph. In all batch optimization 
experiments a 12.5 μg/mL of PIX was used. 
 
FIA procedure  
 
A 100 μL of PIX standard solution (range of 10-250 μg/mL) was injected through the injection 
valve utilizing a syringe. Samples of PIX were injected into the stream of the 5 mM of DMP. 
The resultant solution was mixed with 0.1 M NaOH solution in the reaction coil. Peristaltic 
pump pumped the solutions with a total flow rate of 1.47 mL/min and the absorbance of the 
resulting orange product was measured at 472 nm. A 40 μg/mL of PIX was used during the 
study of the optimum conditions of FI system. 
 
RESULTS AND DISCUSSION 
 
Diazotized metoclopramide has been used as an efficient coupling reagent in several 
spectrophotometric reactions [27, 28]. Most of the amino compounds used for diazotization 
coupling reactions are toxic, especially those contain withdrawing groups (nitro, cyano and halo 
groups). Using a drug compound as a chromogenic reagent is preferred to make the methods 
less expensive and safer. In the present work, an orange dye product results from the coupling of 
PIX with DMP was studied using batch and normal FIA methods. All the parameters that 
enhance the sensitivity of the diazotization reaction and consequently the assay of PIX drug 
were studied. The influence of the chemical and physical parameters such as reagents 
concentrations, the temperature of the reaction, the flow rate, length of reaction coil and sample 
volume were optimized.  
 
Preliminary studies and batch system 
 
The maximum value of absorption was measured at 472 nm versus reagent blank (Figure 2). 
The alkaline medium was found to be essential for development of the colored product because 
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the benzothiazine ring in PIX be more reactive due to conversion of the hydroxyl group to more 
reactive phenoxide in the presence of sodium hydroxide. Therefore, different alkaline solutions 
(sodium hydroxide, ammonium hydroxide, and sodium carbonate) were examined. Maximum 




Figure 2. Absorption spectra of the orange product result from the reaction of 20 µg/mL of PIX 
with DMP/NaOH measured against the blank, and the blank measured against distilled 
water. 
 
When the influence of different volumes of 5 mM of DMP (from 0.25 to 3 mL) and 0.1 M 
NaOH (from 0.1 to 2.5 mL) were studied, maximum absorbances were obtained using 1 mL of 5 
mM DMP and 1.5 mL of 0.1 M sodium hydroxide (Figure 3). The effect of time on the stability 
of absorbance readings after dilution was studied. The absorbance of the product was stable 
after 5 min and remain constant for more than 20 min. Also, variant orders of the addition of the 
reagents were examined and it was found that the following order addition (PIX+DMP+NaOH) 





Figure 3. Effect of the volume of DMP and NaOH. 
 
Scheme 1 is summarized as the supposed mechanism of the reaction. The reagent used in 
this work is an amino drug (MP), which is easily converted to diazonium salt under 
diazotization reaction with nitrous acid (NaNO2/HCl). The diazonium salt then is reacted with 
PIX through the benzothiazine ring (i.e. from benzene ring attached to the 6-membered 
heterocycle thiazine) in alkaline medium. The stoichiometry of the PIX–DMP dye was studied 
















Volume of reagent or base, mL
DMP (5mM)
NaOH (0.1M)
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drug and DMP under the recommended optimum conditions. A stoichiometry of 1:1 PIX:DMP 


























































Primary studies were focused on the optimization of all parameters of FIA system. The manifold 
is considered as a heart of flow system, therefore several flow manifolds (single and double 
channels) were made to perform different reaction paths for the reaction of PIX drug with DMP 
in alkaline medium. A two-channel FI manifold was chosen, which offered a maximum 
absorbance intensity and high sampling frequency. PIX was injected into a stream of DMP, 
which then mixed with sodium hydroxide using mixing coil as given in Figure 1.  
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Optimization of chemical variables 
 
The effect of the concentration of DMP on the analytical signal was studied. A 40 μL of PIX 
was injected into a stream of different concentrations range of DMP (2-10 mM). The results 
(Figure 4A) indicated that a 5 mM gave the best analytical signal and was selected for further 
use. Previous studies indicated that the reaction between PIX and DMP must be performed in an 
alkaline medium. The effect of changing the concentration of NaOH using a range of 
concentration (0.025-0.3 M) was studied. The best result was obtained using 0.1 M sodium 
hydroxide (Figure 4A) which was selected for the following experiments.  
 
Optimization of FIA variables 
 
The influence of the total flow rate of the reagents streams on the sensitivity and sample 
frequency of the reaction was studied using a range of rates between 1.13- 4.80 mL/min under 
the optimum conditions. Figure 4B referred that maximum intensity was obtained with a flow 
rate of 1.47 mL/min, then the absorbance was decreased with increasing the flow rate because of 
increasing the dispersion which decreased residence time and increased reagent consumption. 
The effect of length of the coil (using mixed the solutions) on absorbance was examined in the 
range of 0-200 cm. A significant increase in absorbance (peak height) was observed after 
increasing the coil length up to 75 cm and then decreased (Figure 4C). This may be due to the 
fast coupling reaction between PIX and DMP. Further length of reaction coil causes an increase 
in the dispersion, and peak broadening, hence 75 cm was selected for the subsequent 
experiments. 
The injected sample volume was studied by changing the length of 0.5 mm i.d. sample loop 
in the injection valve to obtain varied volumes from 75 to 200 μL, whereas the other parameters 
remained unchanged (75 cm coil length, 1.47 mL/min flow rate, 0.1 M NaOH, 5 mM DMP 
solution and 40 μg/mL of PIX). The results (Figure 4D) showed an increase in analytical signal 
with an increase in the injected volume up to 100 μL and then decreased. A 100 μL was selected 
to obtained high intensity and low consumption of the sample. The flow system provided a 
sampling frequency of 38 samples h-1.  
 
Calibration plots and limits of detection 
 
The calibration graphs for the analysis of PIX drug using batch and FIA systems were obtained 
using the optimum variables. The calibration graphs were prepared using a series of PIX 
standard solutions and by applying the procedure described in experimental or by injected in 
triplicate to test the linearity for batch and FIA systems, respectively. The slope, correlation 
coefficient, intercept for the calibration data and the sensitivity parameters (molar absorptivity, 
Sandell’s sensitivity, and LOD) are summarized in Table 1. Excellent linearity of the calibration 
graphs was obtained and Beer’s law was obeyed in the range of 1-35 and 10-250 μg/mL of PIX 
for batch and FIA systems, respectively. In comparison between two suggested procedures, FIA 
is more convenient than the batch method because of its wider linear range of calibration graph 
and high throughput samples (38 sample/h). The FIA method is less sensitive than the batch 
method, this may be due to the effect of dispersion of the sample zone inside the carrier and 
reagent solutions arriving at the detector. 
 
Accuracy and precision 
 
The precision of the methods was tested by analyzing three different concentrations of PIX 
solutions according to suggested methods in five replicates. The resulting analytical values have 
been shown in Table 2. The method displayed good accuracy and high precision according to 
the small values of RSD and % Error [29]. 
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Figure 4. Effect of reagent concentrations (A); total flow rate (B); reaction coil (C); and sample 
volume (D). 
 
Table 1. Data for the calibration graphs for batch and FIA methods. 
 
Parameter Batch method FIA method 
Regression equation Y = 0.0346X-0.0204 Y = 0.0012X+0.1218 
Linear range (µg/mL) 1-35 10-250 
Correlation coefficient, r 0.9998 0.9997 
Molar absorptivity, ε (L/mol cm) 1.2×104 0.4×103 
Sandell’s sensitivity, S (μg/cm2) 2.9×10-2 8.3×10-1 
Limit of detection (s/n = 3) (μg/mL) 0.2 3.4 
Limit of quantification (μg/mL) 0.7 11.4 
Reproducibility, % < 0.7 < 2.4 
Through-put (h‾¹) 12 38 
Average of recovery, % 99.0 100.3 
Slope, b (mL/μg) 0.0346 0.0012 








Table 2. Accuracy and precision of the proposed methods. 
 










(Rec. ± SD)% 









(Rec. ± SD)% 
(n = 5) 
1 5 4.8 -4.0 96 ± 0.1 25 24.9 -0.4 99.6 ± 0.2 
2 10 10.3 3.0 103 ± 0.2 75 75.6 0.8 100.8± 0.5 




















Ream Ismail Abed and Hind Hadi 
 
Bull. Chem. Soc. Ethiop. 2020, 34(1) 
20
Study of interference from other substances 
 
To check the efficacy of the proposed methods in the assay of PIX in commercial dosage forms 
(usually involved an additives materials), a recovery testing for 10 μg/mL of PIX was performed 
in the presence of (10-fold) of additives for batch method. The good percentage recoveries 
(97.19-102.16%) were obtained indicating none of these additives interfered significantly and 
the method has good selectivity (Table 3).  
 




Conc. of PIX, μg/ mL (% Recovery ± SD)* 
Present Found 
Poly vinyl pyrrolidone 
10 
10.2 102 ± 0.5 
Talc 10.1 101 ± 1.8 
Starch 9.7 97 ± 0.8 
Magnesium stearate 9.7 97 ± 0.4 




The ruggedness of the suggested methods was established by assaying PIX by different analysts 
using the same conditions at 12.5 and 40 μg/mL of PIX for the batch and FIA methods, 
respectively. The results showed that the % RSD values were less than 2% and 1.5% for batch 
and FIA methods, respectively, indicated the ruggedness of both methods. 
 



















(%)* Taken Found Taken Found Taken Found 
Piroxicam® 
capsules 
(20 mg)  
5 5.1 102.0 4.3 75 76.9 102.5 1.4 5 4.8 96.0 2.2 
10 9.8 98.0 0.9 100 98.7 98.7 1.8 15 14.9 99.3 0.6 




5 4.9 98.0 2.2 75 73.9 98.5 1.9 5 5.1 102.0 2.9 
10 10.1 101.0 1.2 100 101.7 101.7 1.5 15 15.0 100.0 0.7 





5 5.1 102.0 2.3 75 76.1 101.5 1.8 5 5.1 102.0 1.3 
10 10.2 102.0 1.1 100 97.3 97.3 1.6 15 14.8 98.7 0.8 
15 15.2 101.3 2.6 150 154.1 102.7 1.1  
PIX (pure form)  99.0   100.3   99.3  
t (2.45)** 





(n1– 1) = 3 , (n2– 1) = 3 
(n1+  n2– 2) = 6 
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Table 5.Comparison between suggested methods and some literature spectrophotometric methods. 
 
 
Analysis of pharmaceutical samples 
 
The batch and FIA methods were successfully used for the analysis of pharmaceuticals 
(capsules and injection) involved different dosages of PIX and the results are summarized in 
Table 4. The evaluation of the proposed methods was performed by carrying out recovery 
experiments for two types of capsules and one type of injection and the results showed excellent 
recoveries values for both methods and were in good agreement with the declared content. The 
obtained recoveries for both proposed methods were compared successfully with those obtained 
from applying of UV method and measured the absorbance at  352 nm [30, 31]. The F and t-
tests [32] indicated that there are no considerable differences between batch, FI and UV 
methods for the assay of PIX in pharmaceutical dosage forms. Table 5 demonstrates the 




In conclusion, the batch and FI methods suggested for the analysis of PIX in commercial dosage 
forms have the characteristic features of being sensitive, inexpensive, using safely drug 











Ceric ammonium sulfate/ 
promethazine HCl  
Ceric ammonium sulfate/ 
methdilazine HCl 
0.4-7.5      
 
0.2 - 10 










Spectrophotometry Methylene Violet 2-25 --- 1.2 
Involved extraction 
with chloroform and 
need pH control 
14 
Spectrophotometry 
Alizarin, alizarin red S, 





Using organic solvent 
and need pH control 16 
Spectrophotometry  Fe(III) 8–160 0.78 0.1 Low sensitivity 17 
Spectrophotometry Polymethine dye 1.0–20.0 0.49 
0.06-
0.1 
Need pH control, 
extraction with toluene 





(NBS)/chloranilic acid  




FIA- Luminescence Europium (Eu3+) 0.1-1 0.023 2-3 
Toxic and expensive 
reagent, narrow range 












Using organic solvent 







0.009- 9.94    0.003     1.5 





1-35  0.2 0.7 Sensitive not involved 
extraction or heating. 
Using safe and cheap 
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compound as a reagent and wide range of assay with no need for pre-extraction or heating, with 
good precision. High sampling frequency (38 sample/h) and the precision make FI procedure 
appropriate for the quality control of PIX in pharmaceutical formulations and faster than the 
batch methods. Experiments also indicated that there are no significant differences between the 
results obtained from the two proposed methods.  
There are few FIA methods to determine PIX but many of which lack sensitivity, utilise 
toxic reagents or being highly costly. The proposed method in this study utilise cheap and safe 
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